Exploring the Therapeutic Mechanisms of Huzhang–Shanzha Herb Pair against Coronary Heart Disease by Network Pharmacology and Molecular Docking

Figure 8

Detailed target compound interactions in the docking simulation. (a) TNF protein ginsenoside 3,5-dimethyl-4-methoxybenzoic acid. (b) TNF protein ginsenoside caffeic acid dimethyl ether. (c) NF-κB1 protein ginsenoside 3,5-dimethyl-4-methoxybenzoic acid. (d) NF-κB1protein ginsenoside simvastatin. (e) ESR1 protein ginsenoside emodin. (f) ESR1 protein ginsenoside polygalacic acid. (g) ESR1 protein ginsenoside quillaic acid. (h) ESR1 protein ginsenoside resveratrol. (i) ESR1 protein ginsenoside simvastatin. (j) ESR1 protein ginsenoside ursolicacid.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)

(j)